Drugs and brands

Semaglutide

Every GLP-1 the FDA has approved, and the active ingredient inside each one.

What is Semaglutide?

The active ingredient in Wegovy, Ozempic (pen and tablets) and Rybelsus, which Ozempic tablets are replacing in the US.

Its roughly seven-day half-life is what allows weekly injection. When a seller lists “semaglutide” at a fraction of brand pricing, they mean a compounded preparation of this molecule, not the approved product, and their pricing page often blurs the difference.

Semaglutide drug page →

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where Semaglutide comes up on this site

On GLP Watchdog, Semaglutide comes up in 277 research articles, 648 seller reviews, 149 FDA warning letters and 4 tools. Browse the FDA warning letters.

Other terms under Drugs and brands

Where the evidence lives